Refractory Bladder Urothelial Carcinoma

specific

Bladder urothelial carcinoma that does not respond to treatment.

32

Centers

32

Active Trials

Cancer Funding

Top Centers for Refractory Bladder Urothelial Carcinoma(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.6
2
NCI Comprehensive
Active Research Program
51.6
3
NCI Comprehensive
Active Research Program
51.6
4
NCI Comprehensive
Active Research Program
51.6
5
NCI Comprehensive
Active Research Program
51.6
6
NCI Comprehensive
Active Research Program
51.6
7
NCI Comprehensive
Active Research Program
51.6
8
NCI Comprehensive
Active Research Program
51.6
9
NCI Comprehensive
Active Research Program
51.6
10
NCI Comprehensive
Active Research Program
51.6
11
NCI Comprehensive
Active Research Program
51.6
12
NCI Comprehensive
Active Research Program
51.6
13
NCI Comprehensive
Active Research Program
51.6
14
NCI Comprehensive
Active Research Program
51.6
15
NCI Comprehensive
Active Research Program
51.6
16
NCI Comprehensive
Active Research Program
51.6
17
NCI Clinical
Active Research Program
51.6
18
NCI Comprehensive
Active Research Program
51.6
19
NCI Comprehensive
Active Research Program
51.6
20
Active Research Program
51.6
21
Active Research Program
51.6
22
NCI Clinical
Active Research Program
51.6
23
NCI Comprehensive
Active Research Program
51.6
24
Active Research Program
51.6
25
NCI Comprehensive
Active Research Program
51.6
26
Active Research Program
51.6
2751.6
28
Active Research Program
51.6
29
Active Research Program
51.6
30
Active Research Program
51.6
31
Active Research Program
51.6
32
Active Research Program
51.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →